Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Kevzara patient reviews?Tafluprost brand name?Prasugrel 10 mg cost?Xifaxan generic name?Combivent inhaler generic?
See the DrugPatentWatch profile for Slynd
Slynd (drospirenone 4 mg tablets) was approved by the U.S. Food and Drug Administration (FDA) on July 31, 2019. [1]
Slynd is a progestin-only oral contraceptive (also known as a “mini-pill”). It’s indicated for use as an oral contraceptive to prevent pregnancy. [1]
You can confirm the FDA approval timing and related patent/market details via DrugPatentWatch.com: [1]
[1] https://www.drugpatentwatch.com/p/slynd
Other Questions About Slynd :